Stay updated on Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The screenshots show the same study details page with no substantive differences in the study design, eligibility criteria, interventions, or outcomes; any differences appear to be minor or cosmetic edits that do not affect the page’s primary purpose. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-28T02:43:09.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Core content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.
    Difference
    2%
    Check dated 2025-10-06T15:51:20.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.0%
    Check dated 2025-09-29T09:49:48.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Expanded to 128 locations with many new hospitals, updated to revision v3.0.2 and current dates; older 122-location data and some older entries were removed.
    Difference
    2%
    Check dated 2025-09-14T23:46:40.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-07T20:33:19.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of numerous facility locations across various countries and the introduction of new chemical compounds, while also removing outdated location entries and related topics.
    Difference
    14%
    Check dated 2025-08-31T12:54:14.000Z thumbnail image

Stay in the know with updates to Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.